Doctor profile · Federal record
Dr. Namrata Dhillon, MD
Rheumatology Physician (CMS: Rheumatology) · Columbus, OH
- NPI 1689988099
- Accepts Medicare
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1211 Dublin RD
Columbus, OH 432151077
(614) 486-5200
fax (614) 486-9665 - Additional location
-
170 Taylor Station RD Ste 300
Columbus, OH 432134491
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- August 26, 2025
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Ohio #35.121393
- Medicaid
- OH #0088794
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689988099. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
60,086
Distinct HCPCS
10
Medicare allowed
$921,118
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 27,160 | 16 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 15,250 | 28 | $12 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,310 | 59 | $32 | |
J0897 |
Injection, denosumab, 1 mg | 3,480 | 38 | $23 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,000 | 23 | $42 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 571 | 256 | $121 | |
86235 |
Measurement of antibody for assessment of autoimmune disorder, any method | 478 | 101 | $17 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 434 | 235 | $3 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 419 | 230 | $5 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 416 | 240 | $8 |
In context: peer comparison
Among 18 peers in Columbus Rheumatology Physician, average services per provider: 1,015. This provider delivers 59× the peer median.Open Payments
Industry payments received
All-time total
$764
Transactions
30
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 14 | $263.74 | |
| Janssen Scientific Affairs, LLC | 2 | $249.17 | |
| Pfizer INC. | 4 | $80.57 | |
| GlaxoSmithKline, LLC. | 3 | $58.31 | |
| Amgen INC. | 3 | $43.68 | |
| Ucb, INC. | 2 | $34.80 | |
| Janssen Biotech, INC. | 2 | $33.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,956
Patients
674
Total drug cost
$710,432
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 437 | 176 | $4,485 |
| Hydroxychloroquine Sulfate | Generic | 286 | 98 | $28,627 |
| Methotrexate (Methotrexate Sodium) | Brand | 252 | 72 | $14,001 |
| Gabapentin | Generic | 229 | 69 | $3,821 |
| Tramadol Hcl | Generic | 160 | 58 | $1,310 |
| Celecoxib | Generic | 93 | 37 | $5,950 |
| Allopurinol | Generic | 85 | 28 | $1,072 |
| Methylprednisolone | Generic | 82 | 46 | $1,138 |
| Duloxetine Hcl | Generic | 67 | 27 | $3,081 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 62 | 11 | $718 |
Frequently asked questions
What is Dr. Namrata Dhillon's medical specialty?
Dr. Namrata Dhillon practices Rheumatology Physician in Columbus, OH.
Where does Dr. Namrata Dhillon practice?
Dr. Namrata Dhillon practices at 1211 Dublin RD, Columbus, OH 432151077. Office phone: 6144865200.
What is Dr. Namrata Dhillon's NPI?
Dr. Namrata Dhillon's National Provider Identifier (NPI) is 1689988099, issued by NPPES.
Does Dr. Namrata Dhillon accept Medicare assignment?
Yes. Dr. Namrata Dhillon accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Namrata Dhillon commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.